Denali Therapeutics Inc. (DNLI) › Total AssetsDenali Therapeutics Inc. (DNLI) — Total AssetsAnnual figures by fiscal year, from SEC filings.2017: $486.72M2018: $661.98M2019: $553.23M2020: $1.60B2021: $1.40B2022: $1.46B2023: $1.15B2024: $1.37B2025: $1.14B$1.14B2017Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$1.14B-16.7%2024$1.37B+19.1%2023$1.15B-21.0%2022$1.46B+4.0%2021$1.40B-12.5%2020$1.60B+190.0%2019$553.23M-16.4%2018$661.98M+36.0%2017$486.72M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share